Treatment and prevention of herpes genital infection
Adrian Mindel
Abstract
Adrian Mindel
Abstract
The recent introduction of acyclovir for the treatment of genital herpes offers new hope for sufferers of this troublesome and recurrent condition. The results of the published trials with acyclovir in both primary and recurrent genital herpes are reviewed. The results show that acyclovir is a useful drug for the treatment of primary infections, but has a limited role in treating recurrences. Preliminary results with prophylactic oral acyclovir suggest that this form of therapy may be useful in patients with frequent severe recurrences.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The recent introduction of acyclovir for the treatment of genital herpes offers new hope for sufferers of this troublesome and recurrent condition. The results of the published trials with acyclovir in both primary and recurrent genital herpes are reviewed. The results show that acyclovir is a useful drug for the treatment of primary infections, but has a limited role in treating recurrences. Preliminary results with prophylactic oral acyclovir suggest that this form of therapy may be useful in patients with frequent severe recurrences.
Key concepts: Medicine, Sex organ, Genital herpes, Family medicine, Virology, Biology, Virus, Genetics